Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20616507rdf:typepubmed:Citationlld:pubmed
pubmed-article:20616507lifeskim:mentionsumls-concept:C0032019lld:lifeskim
pubmed-article:20616507lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:20616507lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:20616507lifeskim:mentionsumls-concept:C0418981lld:lifeskim
pubmed-article:20616507pubmed:dateCreated2010-7-9lld:pubmed
pubmed-article:20616507pubmed:abstractTextDespite considerable progress, there is still no medical treatment available for some kinds of pituitary tumors, in particular hormone inactive adenomas and corticotroph pituitary tumors. Surgical removal or at least debulking of the tumor is the only option to treat these kinds of tumors apart from rarely applied radiotherapy. Moreover, treatment resistance is present in a considerable proportion of patients bearing pituitary tumors, for which medical treatment regimens are already available (prolactinomas, somatotroph adenomas). Thus, novel or improved medical treatment strategies would be desirable. Here, we summarize preclinical and clinical findings about the hormone and growth-suppressive action of various drugs, which will probably lead to novel future medical treatment concepts for pituitary tumors.lld:pubmed
pubmed-article:20616507pubmed:languageenglld:pubmed
pubmed-article:20616507pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:citationSubsetIMlld:pubmed
pubmed-article:20616507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20616507pubmed:statusMEDLINElld:pubmed
pubmed-article:20616507pubmed:issn0301-3073lld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:HaedeWWlld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:RennerUUlld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:ArztEElld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:StallaG KGKlld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:Theodoropoulo...lld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:LabeurMMlld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:Paez PeredaMMlld:pubmed
pubmed-article:20616507pubmed:authorpubmed-author:PeroneM JMJlld:pubmed
pubmed-article:20616507pubmed:copyrightInfoCopyright (c) 2010 S. Karger AG, Basel.lld:pubmed
pubmed-article:20616507pubmed:issnTypePrintlld:pubmed
pubmed-article:20616507pubmed:volume38lld:pubmed
pubmed-article:20616507pubmed:ownerNLMlld:pubmed
pubmed-article:20616507pubmed:authorsCompleteYlld:pubmed
pubmed-article:20616507pubmed:pagination158-64lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:meshHeadingpubmed-meshheading:20616507...lld:pubmed
pubmed-article:20616507pubmed:year2010lld:pubmed
pubmed-article:20616507pubmed:articleTitleNovel medical therapies for pituitary tumors.lld:pubmed
pubmed-article:20616507pubmed:affiliationMax Planck Institute of Psychiatry, Department of Neuroendocrinology, Munich, Germany.lld:pubmed
pubmed-article:20616507pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20616507pubmed:publicationTypeReviewlld:pubmed